Valérie Ondet

Learn More
BACKGROUND Volatiles organic compounds (VOCs) in urine have been proposed as cancer biomarkers. OBJECTIVE To evaluate the efficacy of prostate cancer (PCa) detection by trained dogs on human urine samples. DESIGN, SETTING, AND PARTICIPANTS A Belgian Malinois shepherd was trained by the clicker training method (operant conditioning) to scent and(More)
PURPOSE Few risk factors have been identified for renal cell carcinoma. We performed a validation study in a population with a European background to identify the most significant variants previously identified in association with renal cell carcinoma risk. MATERIALS AND METHODS We performed a case-control validation study after recruiting 463 controls(More)
Bladder carcinoma (B-TCC) is the fifth most prevalent carcinoma in the United States (US) or Europe. In addition, B-TCC is the most expensive carcinoma per patient between diagnosis and death, because of its 50–80 % recurrence rate. B-TCC is an optimal carcinoma for which to detect DNA alterations in urine, which is easily obtainable. Chromosomal(More)
UNLABELLED Prostate-specific antigen (PSA) is still the cornerstone of prostate cancer (PCa) screening and diagnosis in both research and current clinical practice. Inaccuracy of PSA is partly due to the influence of a number of genetic, clinical, and biological factors modifying PSA blood levels. In the present study, we detailed the respective influence(More)
INTRODUCTION Urothelial carcinomas are the fourth leading cause of cancer in humans. Their incidence is increasing by more than 50% in 25 years. The superficial forms (70% cases) require a close active surveillance to identify frequent recurrences and progression to invasive stage. Our main goal was to identify prognostic molecular markers for bladder(More)
  • 1